Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2025-12-25 @ 9:04 PM
Study NCT ID:
NCT04954456
Status:
UNKNOWN
Last Update Posted:
2021-09-20
First Post:
2021-06-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-01
First Submit QC Date:
None
Study First Post Date:
2021-07-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-13
Last Update Post Date:
2021-09-20
Last Update Post Date Type:
ACTUAL